SPOTLIGHT: Lymphoma drugs often avoided

July 16, 2007
Email LinkedIn
Tools


Only a fraction of the patients who could benefit from lymphoma drugs like Bexxar and Zevalin actually get them, largely because doctors get reimbursed on other therapies or are reluctant to refer patients to competing academic centers. Report

Filed Under

, ,

Comments

Press Releases

Featured Jobs